350
Views
6
CrossRef citations to date
0
Altmetric
Review

New fixed dose chemical combinations: the way forward for better diabetes type II management?

, &
Pages 2207-2214 | Received 25 Jul 2016, Accepted 20 Sep 2016, Published online: 17 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ildiko Lingvay, Nadine Beetz, Regina Sennewald, Annette Schuler-Metz, Julia Bertulis, Christina Loley, Benjamin Lang, Caroline Lippert, Jisoo Lee, Linda Shapiro Manning & Derek Terada. (2020) Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes. Postgraduate Medicine 132:4, pages 337-345.
Read now
André J. Scheen. (2017) Dapagliflozin and saxagliptin tablets for adults with type 2 diabetes. Expert Review of Clinical Pharmacology 10:12, pages 1303-1316.
Read now
Xueying Tan, Xiaojing Cao, Minzhi Zhou, Ping Zou & Jingbo Hu. (2017) Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes. Expert Opinion on Investigational Drugs 26:9, pages 1083-1089.
Read now
André J. Scheen. (2017) Pharmacotherapy of ‘treatment resistant’ type 2 diabetes. Expert Opinion on Pharmacotherapy 18:5, pages 503-515.
Read now

Articles from other publishers (2)

Xiaoying Zhao, Rui Ning, Andrew Hui, David W. Boulton & Weifeng Tang. (2023) Pharmacokinetic Variables of Dapagliflozin/Metformin Extended-Release Fixed-Dose Combination in Healthy Chinese Volunteers and Regional Comparison. Clinical Therapeutics.
Crossref
Kurt Ritter. 2003. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry 1 37 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.